300 related articles for article (PubMed ID: 11815398)
1. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese.
Gao C; Takezaki T; Wu J; Li Z; Wang J; Ding J; Liu Y; Hu X; Xu T; Tajima K; Sugimura H
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):29-34. PubMed ID: 11815398
[TBL] [Abstract][Full Text] [Related]
2. Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
Tan W; Song N; Wang GQ; Liu Q; Tang HJ; Kadlubar FF; Lin DX
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):551-6. PubMed ID: 10868687
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1.
Lin DX; Tang YM; Peng Q; Lu SX; Ambrosone CB; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1013-8. PubMed ID: 9829710
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP2E1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
Morita M; Le Marchand L; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Imaizumi N
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):235-41. PubMed ID: 19124503
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
Hildesheim A; Chen CJ; Caporaso NE; Cheng YJ; Hoover RN; Hsu MM; Levine PH; Chen IH; Chen JY; Yang CS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):607-10. PubMed ID: 8547826
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
[TBL] [Abstract][Full Text] [Related]
9. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
10. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
11. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
[TBL] [Abstract][Full Text] [Related]
13. [Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study].
Yu WP; Chen K; Ma XY; Yao KY; Jiang QT; Zou Y; Zhou HG
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 May; 38(3):162-6. PubMed ID: 15182482
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of CYP2E1 and risk of colorectal adenomas in the Self Defense Forces Health Study.
Morita M; Tabata S; Tajima O; Yin G; Abe H; Kono S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1800-7. PubMed ID: 18628434
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphisms of cytochrome P450 2E1 and glutathione S-transferase P1 and susceptibility to esophageal cancer].
Lin D; Tang Y; Peng Q
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):94-7. PubMed ID: 10920953
[TBL] [Abstract][Full Text] [Related]
17. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms.
Sugimura T; Kumimoto H; Tohnai I; Fukui T; Matsuo K; Tsurusako S; Mitsudo K; Ueda M; Tajima K; Ishizaki K
J Oral Pathol Med; 2006 Jan; 35(1):11-8. PubMed ID: 16393248
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.
De Roos AJ; Rothman N; Inskip PD; Linet MS; Shapiro WR; Selker RG; Fine HA; Black PM; Pittman GS; Bell DA
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):14-22. PubMed ID: 12540498
[TBL] [Abstract][Full Text] [Related]
19. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
20. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.
Zheng W; Gao YT; Shu XO; Wen W; Cai Q; Dai Q; Smith JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):709-14. PubMed ID: 15159300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
